Key facts
- This page summarizes J.H. Whitney Equity Partners VII, LLC's Form 4 filing for Aveanna Healthcare Holdings, Inc. (AVAH).
- 4 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 24 Aug 2026, 18:26.
J.H. Whitney Equity Partners VII, LLC - 20 Aug 2026 Form 4 Insider Report for Aveanna Healthcare Holdings, Inc. (AVAH)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- AVAH
- Reported as of
- 20 Aug 2026
- Net transaction value
- -$169,579,886
- SEC form
- 4
- Accepted by SEC
- 24 Aug 2026, 18:26:47 UTC
- Prior SEC filing
- 02 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ David Zatlukal, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
J.H. Whitney Equity Partners VII, LLC filed Form 4 for Aveanna Healthcare Holdings, Inc. (AVAH) on 24 Aug 2026.
Change
- Previous filing in this sequence was filed on 02 Jul 2026.
- Current net transaction value: -$169,579,886.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001567459
Primary reporting owner
J.H. Whitney Equity Partners VII, LLC
- Relationship
- 10%+ Owner
- Address
- 212 ELM STREET, NEW CANAAN
- Signature
- /s/ David Zatlukal, Attorney-in-Fact
- Signature date
- 24 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
AVAH
transaction
Common Stock, $0.01 par value
Sale
- Transaction value
- $116,289,438
- Shares
- -10,112,125
- Change %
- -100%
- Price
- $11.50
- Shares after
- 0
- Date
- 20 Aug 2026
- Ownership
- By J.H. Whitney VII, L.P.
- Footnotes
- F1, F2
AVAH
transaction
Common Stock, $0.01 par value
Sale
- Transaction value
- $11,016,057
- Shares
- -957,918
- Change %
- -6.2%
- Price
- $11.50
- Shares after
- 14,565,892
- Date
- 20 Aug 2026
- Ownership
- By PSA Healthcare Investment Holding LLC
- Footnotes
- F1, F3
AVAH
transaction
Common Stock, $0.01 par value
Sale
- Transaction value
- $16,399,391
- Shares
- -1,426,034
- Change %
- -100%
- Price
- $11.50
- Shares after
- 0
- Date
- 20 Aug 2026
- Ownership
- By PSA Iliad Holdings LLC
- Footnotes
- F1, F4
AVAH
transaction
Common Stock, $0.01 par value
Sale
- Transaction value
- $25,875,000
- Shares
- -2,250,000
- Change %
- -15%
- Price
- $11.50
- Shares after
- 12,315,892
- Date
- 21 Aug 2026
- Ownership
- By PSA Healthcare Investment Holding LLC
- Footnotes
- F1, F5
AVAH
holding
Common Stock, $0.01 par value
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 0
- Date
- 20 Aug 2026
- Ownership
- Direct
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
J.H. Whitney Equity Partners VII, LLC is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 5 footnotes
Footnote F1
J.H. Whitney Equity Partners VII, LLC ("Equity Partners VII") is the general partner of J.H. Whitney VII, L.P. ("JHW VII") and Whitney Strategic Partners VII, L.P. ("Strategic Partners VII"). Strategic Partners VII is the managing member of each of PSA Healthcare Investment Holdings LLC ("PSA Healthcare") and PSA Iliad Holdings LLC ("PSA Iliad Holdings," and, collectively with JHW VII and PSA Healthcare, the "Stockholder Entities"). As a result, Equity Partners VII may be deemed to share voting and dispositive power with respect to shares of common stock, $0.01 par value per share (the "Shares"), held by each of the Stockholder Entities, and Strategic Partners VII may be deemed to share voting and dispositive power with respect to the Shares held by each of PSA Healthcare and PSA Iliad Holdings. Each of Equity Partners VII and Strategic Partners VII disclaims beneficial ownership of such securities except to the extent of its pecuniary interest therein.
Footnote F2
On August 20, 2026, J.H. Whitney VII, L.P sold 10,112,125 Shares pursuant to an underwritten secondary offering.
Footnote F3
On August 20, 2026, PSA Healthcare Investment Holding LLC sold 957,918 Shares pursuant to an underwritten secondary offering.
Footnote F4
On August 20, 2026, PSA Iliad Holdings LLC sold 1,426,034 Shares pursuant to an underwritten secondary offering.
Footnote F5
On August 21, 2026, PSA Healthcare Investment Holding LLC sold 2,250,000 Shares pursuant to the option to purchase additional Shares in an underwritten secondary offering.